Cargando…

Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway

Malaria is a major parasitic disease of humans and is a health public problem that affects more than 100 countries. In 2017, it caused nearly half a million deaths out of 219 million infections. Malaria is caused by the protozoan parasites of the genus Plasmodium and is transmitted by female mosquit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kluck, George Eduardo Gabriel, Wendt, Camila Hübner Costabile, Eustaquio do Imperio, Guinever, Araujo, Maria Fernanda Carvalho, Atella, Tainá Correa, da Rocha, Isabella, Miranda, Kildare Rocha, Atella, Georgia Correa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789167/
https://www.ncbi.nlm.nih.gov/pubmed/31604978
http://dx.doi.org/10.1038/s41598-019-51193-x
_version_ 1783458593746452480
author Kluck, George Eduardo Gabriel
Wendt, Camila Hübner Costabile
Eustaquio do Imperio, Guinever
Araujo, Maria Fernanda Carvalho
Atella, Tainá Correa
da Rocha, Isabella
Miranda, Kildare Rocha
Atella, Georgia Correa
author_facet Kluck, George Eduardo Gabriel
Wendt, Camila Hübner Costabile
Eustaquio do Imperio, Guinever
Araujo, Maria Fernanda Carvalho
Atella, Tainá Correa
da Rocha, Isabella
Miranda, Kildare Rocha
Atella, Georgia Correa
author_sort Kluck, George Eduardo Gabriel
collection PubMed
description Malaria is a major parasitic disease of humans and is a health public problem that affects more than 100 countries. In 2017, it caused nearly half a million deaths out of 219 million infections. Malaria is caused by the protozoan parasites of the genus Plasmodium and is transmitted by female mosquitoes of the genus Anopheles. Once in the bloodstream, Plasmodium merozoites invade erythrocytes and proliferate until the cells lyses and release new parasites that invade other erythrocytes. Remarkably, they can manipulate the vertebrate host’s lipid metabolism pathways, since they cannot synthesize lipid classes that are essential for their development and replication. In this study, we show that mice infected with Plasmodium chabaudi present a completely different plasma profile from control mice, with marked hyperproteinemia, hypertriglyceridemia, hypoglycemia, and hypocholesterolemia. In addition, white adipose and hepatic tissue and analyses from infected animals revealed the accumulation of triacylglycerol in both tissues and free fatty acids and free cholesterol in the liver. Hepatic mRNA and protein expression of key enzymes and transcription factors involved in lipid metabolism were also altered by P. chabaudi infection, leading to a lipogenic state. The enzyme 5′ AMP-activated protein kinase (AMPK), a master regulator of cell energetic metabolism, was also modulated by the parasite, which reduced AMPK phosphorylation levels upon infection. Pretreatment with metformin for 21 days followed by infection with P. chabaudi was effective in preventing infection of mice and also lowered the hepatic accumulation of lipids while activating AMPK. Together, these results provide new and important information on the specific molecular mechanisms induced by the malaria parasite to regulate hepatic lipid metabolism in order to facilitate its development, proliferation, and lifespan in its vertebrate host.
format Online
Article
Text
id pubmed-6789167
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-67891672019-10-21 Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway Kluck, George Eduardo Gabriel Wendt, Camila Hübner Costabile Eustaquio do Imperio, Guinever Araujo, Maria Fernanda Carvalho Atella, Tainá Correa da Rocha, Isabella Miranda, Kildare Rocha Atella, Georgia Correa Sci Rep Article Malaria is a major parasitic disease of humans and is a health public problem that affects more than 100 countries. In 2017, it caused nearly half a million deaths out of 219 million infections. Malaria is caused by the protozoan parasites of the genus Plasmodium and is transmitted by female mosquitoes of the genus Anopheles. Once in the bloodstream, Plasmodium merozoites invade erythrocytes and proliferate until the cells lyses and release new parasites that invade other erythrocytes. Remarkably, they can manipulate the vertebrate host’s lipid metabolism pathways, since they cannot synthesize lipid classes that are essential for their development and replication. In this study, we show that mice infected with Plasmodium chabaudi present a completely different plasma profile from control mice, with marked hyperproteinemia, hypertriglyceridemia, hypoglycemia, and hypocholesterolemia. In addition, white adipose and hepatic tissue and analyses from infected animals revealed the accumulation of triacylglycerol in both tissues and free fatty acids and free cholesterol in the liver. Hepatic mRNA and protein expression of key enzymes and transcription factors involved in lipid metabolism were also altered by P. chabaudi infection, leading to a lipogenic state. The enzyme 5′ AMP-activated protein kinase (AMPK), a master regulator of cell energetic metabolism, was also modulated by the parasite, which reduced AMPK phosphorylation levels upon infection. Pretreatment with metformin for 21 days followed by infection with P. chabaudi was effective in preventing infection of mice and also lowered the hepatic accumulation of lipids while activating AMPK. Together, these results provide new and important information on the specific molecular mechanisms induced by the malaria parasite to regulate hepatic lipid metabolism in order to facilitate its development, proliferation, and lifespan in its vertebrate host. Nature Publishing Group UK 2019-10-11 /pmc/articles/PMC6789167/ /pubmed/31604978 http://dx.doi.org/10.1038/s41598-019-51193-x Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Kluck, George Eduardo Gabriel
Wendt, Camila Hübner Costabile
Eustaquio do Imperio, Guinever
Araujo, Maria Fernanda Carvalho
Atella, Tainá Correa
da Rocha, Isabella
Miranda, Kildare Rocha
Atella, Georgia Correa
Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway
title Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway
title_full Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway
title_fullStr Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway
title_full_unstemmed Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway
title_short Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway
title_sort plasmodium infection induces dyslipidemia and a hepatic lipogenic state in the host through the inhibition of the ampk-acc pathway
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789167/
https://www.ncbi.nlm.nih.gov/pubmed/31604978
http://dx.doi.org/10.1038/s41598-019-51193-x
work_keys_str_mv AT kluckgeorgeeduardogabriel plasmodiuminfectioninducesdyslipidemiaandahepaticlipogenicstateinthehostthroughtheinhibitionoftheampkaccpathway
AT wendtcamilahubnercostabile plasmodiuminfectioninducesdyslipidemiaandahepaticlipogenicstateinthehostthroughtheinhibitionoftheampkaccpathway
AT eustaquiodoimperioguinever plasmodiuminfectioninducesdyslipidemiaandahepaticlipogenicstateinthehostthroughtheinhibitionoftheampkaccpathway
AT araujomariafernandacarvalho plasmodiuminfectioninducesdyslipidemiaandahepaticlipogenicstateinthehostthroughtheinhibitionoftheampkaccpathway
AT atellatainacorrea plasmodiuminfectioninducesdyslipidemiaandahepaticlipogenicstateinthehostthroughtheinhibitionoftheampkaccpathway
AT darochaisabella plasmodiuminfectioninducesdyslipidemiaandahepaticlipogenicstateinthehostthroughtheinhibitionoftheampkaccpathway
AT mirandakildarerocha plasmodiuminfectioninducesdyslipidemiaandahepaticlipogenicstateinthehostthroughtheinhibitionoftheampkaccpathway
AT atellageorgiacorrea plasmodiuminfectioninducesdyslipidemiaandahepaticlipogenicstateinthehostthroughtheinhibitionoftheampkaccpathway